Kidney and Cardiovascular Effectiveness of Empagliflozin Compared With Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes

Study evaluates the impact of SGLT2 inhibitors on cardiac remodeling in heart failure patients, showing benefits in left ventricular structure and function.